Back
Supernus Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
SUPN
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
38
SUPN
Supernus Pharmaceuticals
Last Price:
30.09
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!Supernus Pharmaceuticals Price Quote
$30.09
+0.03 (+0%)
(Updated: May 2, 2024 at 3:56 AM ET)
Supernus Pharmaceuticals Key Stats
Sell
38
Supernus Pharmaceuticals (SUPN)
is a Sell
Day range:
$29.99 - $30.69
52-week range:
$21.99 - $38.09
Dividend yield:
0%
P/E ratio:
1,503.00
P/S ratio:
2.81
P/B ratio:
1.79%
Volume:
348.1K
Avg. volume:
369.9K
1-year change:
-18.65%
Market cap:
$1.6B
Revenue:
$607.5M
EPS:
$-0
How Much Does Supernus Pharmaceuticals Make?
-
How Much Are Supernus Pharmaceuticals's Sales Annually?
SUPN Revenues are $607.5M -
How Much Profit Does Supernus Pharmaceuticals's Make A Year?
SUPN net income is $1.3M
Is Supernus Pharmaceuticals Growing As A Company?
-
What Is Supernus Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.02% -
What Is Supernus Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.96%
Supernus Pharmaceuticals Stock Price Performance
-
Did Supernus Pharmaceuticals Stock Go Up Last Month?
Supernus Pharmaceuticals share price went down by -10.32% last month -
Did SUPN's Share Price Rise Over The Last Year?
SUPN share price fell by -18.65% over the past 1 year
What Is Supernus Pharmaceuticals 52-Week High & Low?
-
What Is Supernus Pharmaceuticals’s 52-Week High Share Price?
Supernus Pharmaceuticals has traded as high as $38.09 over the past 52 weeks -
What Is Supernus Pharmaceuticals’s 52-Week Low Share Price?
Supernus Pharmaceuticals has traded as low as $21.99 over the past 52 weeks
Supernus Pharmaceuticals Price To Free Cash Flow
-
Is Supernus Pharmaceuticals Stock Overvalued?
Supernus Pharmaceuticals is trading at a price to free cash flow ratio of 15.42 -
Is Supernus Pharmaceuticals Stock Undervalued?
Supernus Pharmaceuticals EV to Free Cash Flow ratio is 12.58 -
What Is Supernus Pharmaceuticals’s Price Earnings Growth Ratio?
SUPN PEG ratio is 0.00 -
Is Supernus Pharmaceuticals Trading At A Premium To Earnings?
Supernus Pharmaceuticals EV to EBIT ratio is 268.22
Is It Risky To Buy Supernus Pharmaceuticals?
-
How Much Debt Does Supernus Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Supernus Pharmaceuticals Have?
Cash and short term investments quarterly total is $254.9M -
What Is Supernus Pharmaceuticals’s Book Value Per Share?
Book value per share is 16.84
Is Supernus Pharmaceuticals Cash Flow Positive?
-
What Is SUPN Cash Flow From Operations?
Cash flow from operations (TTM) is $111.1M -
What Is Supernus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$397.9M -
What Is Supernus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $268.7M
Supernus Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SUPN return on invested capital is 0.12% -
What Is Supernus Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 0.09% -
What Is SUPN Return On Equity?
ROE is a measure of profitability and is 0.15%
Supernus Pharmaceuticals Earnings Date & Stock Price
-
What Is Supernus Pharmaceuticals's Stock Price Today?
A single share of SUPN can be purchased today for 30.06 -
What Is Supernus Pharmaceuticals’s Stock Symbol?
Supernus Pharmaceuticals trades on the nasdaq under the ticker symbol: SUPN -
When Is Supernus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Supernus Pharmaceuticals is scheduled on May 8, 2024 -
When Is SUPN's next ex-dividend date?
Supernus Pharmaceuticals's next ex-dividend date is May 7, 2020 -
How To Buy Supernus Pharmaceuticals Stock?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Supernus Pharmaceuticals Competitors
-
Who Are Supernus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Supernus Pharmaceuticals or are related in some way:
Supernus Pharmaceuticals Dividend Yield
Data Unavailable
Supernus Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -95.95% | 61.03% |
Revenue: | -1.8% | 5.99% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 40.33 |
Upside from Last Price: | 34.18% |